Company intelligence / Profile preview

Wisdom Bioscience

Yorba Linda, California, United Stateswisdombioscience.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Wisdom Bioscience has developed and commercialized a proprietary, IP-protected molecular diagnostic test for the early detection of oral cancer. The technology is designed to be accessible and affordable for dental providers and patients, aiming to enable broad adoption of gold-standard testing. The company is led by an experienced team with deep expertise in clinical diagnostics and molecular biology.

Therapeutic areas: Oncology
Modalities: Diagnostic test (molecular diagnostic)
Industry: Molecular Diagnostics

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Wisdom Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wisdom Bioscience.

Explore the full profile